Taking people in Svédország1. fázis
A double-blind, randomised, placebo-controlled first-in-human/Phase Ib trial to investigate safety, tolerability, pharmacokinetics, and preliminary efficacy of single and multiple doses of TIR-C 2% cutaneous emulsion in adults with mild to moderate atopic dermatitis
Key facts
- Where
- Linkoping, Moelndal, Solna és Uppsala, SvédországSee the 4 sites
- Phase
- 1. fázis
Where in Svédország
- CTC Clinical Trial Consultants ABLinkoping, SvédországTaking people
- CTC Clinical Trial Consultants ABMoelndal, SvédországTaking people
- CTC Clinical Trial Consultants ABSolna, SvédországTaking people
- CTC Clinical Trial Consultants ABUppsala, SvédországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Pharmability AB
- Trial code
- EU 2026-526343-35-00
- Record updated
- 2026. november 5.